ArriVent BioPharma, Inc. Common StockAVBPNASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-94.31M
↓ 76% below average
Average (3y)
$-53.63M
Historical baseline
Range
High:$-8.70M
Low:$-94.31M
CAGR
+121.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-94.31M | -26.4% |
| 2023 | $-74.59M | -102.1% |
| 2022 | $-36.91M | -324.4% |
| 2021 | $-8.70M | - |